Drug data last refreshed 12h ago · AI intelligence enriched 3w ago
Ortho Tri-Cyclen is an oral contraceptive tablet containing norgestimate and ethinyl estradiol in a triphasic formulation. It is indicated for prevention of pregnancy in women of childbearing age. The drug works by suppressing ovulation through hormonal mechanisms.
As LOE approaches, brand team focus will shift from growth maintenance to lifecycle extension strategies and managed decline planning.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects
To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)
Working on Ortho Tri-Cyclen offers stability in a mature, well-established contraceptive franchise, but limited growth and innovation opportunities. Career progression will depend on company restructuring strategy and ability to manage LOE transition.
Worked on ORTHO TRI-CYCLEN at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.